2020 annual financial data
Anika Therapeutics 2020 Operating margin
Direct answer
Operating margin was -21.71%.
Operating income was -28,322,000 USD and net income was -23,982,000 USD.
Operating cash flow was 13,065,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 130,457,000 USD
- Operating income
- -28,322,000 USD
- Net income
- -23,982,000 USD
- Operating cash flow
- 13,065,000 USD